Rising prevalence of cancer, diabetes, and hepatitis B, and growing focus on various drug development initiatives are key factors boosting revenue growth of the global market
Vancouver, BC -- (SBWIRE) -- 04/19/2021 -- The global RNA transcriptomics market size is expected to reach USD 12.46 Billion in 2028 at a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to increasing application of RNA sequencing in drug discovery, rising investment in pharmaceutical research by governments and various private investors, and increasing demand for customized medicines. RNA transcriptome analysis helps researchers to understand the distribution of genes and functional patterns of each gene present in an organism.
This analysis assesses all elements of a transcript, such as non-coding RNAs, mRNAs, and microRNAs, to identify the transcriptional structure of genes and quantify each transcript's changing behavior at the development stage. Transcriptomics has a variety of applications in diagnostics and disease analysis. Transcriptome analysis has been widely used to study heterogeneity of tumors, classify tumors into molecular subtypes, and examine treatment therapy and patient outcomes.
Get Free Sample PDF Copy of this Report At: https://www.emergenresearch.com/request-sample/610
Market Dynamics:
The report offers insightful information about the market dynamics of the RNA Transcriptomics market. It offers SWOT analysis, PESTEL analysis, and Porter's Five Forces analysis to present a better understanding of the RNA Transcriptomics market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the RNA Transcriptomics market.
The key players profiled in the report are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Illumina, Inc., GenXPro GmbH, Fluidigm Corporation, CD Genomics, Sequentia Biotech SL, and Acobiom.
For the purpose of this report, Emergen Research has segmented the global RNA transcriptomics market based on product, technology, application, end-use, and region:
Product Outlook (Revenue: USD Billion; 2018–2028)
Reagents
Instruments
Software
Service
Technology Outlook (Revenue: USD Billion; 2018–2028)
Microarrays
Polymerase Chain Reaction
RNA Sequencing
RNA Interference
Application Outlook (Revenue: USD Billion; 2018–2028)
Clinical Diagnostics
Toxicogenomics
Drug Discovery
Comparative Transcriptomics
End-use Outlook (Revenue: USD Billion; 2018–2028)
Hospitals
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/rna-transcriptomics-market
Key Geographies Profiled in the Report:
North America(the U.S., Mexico, and Canada)
Asia Pacific(China, Japan, India, and Rest of Asia Pacific)
Europe(the U.K., France, Germany, and Rest of Europe)
Latin America(Brazil and Rest of Latin America)
Middle East & Africa(GCC Countries and Rest of Middle East & Africa)
Radical Highlights of the RNA Transcriptomics Market Report:
Comprehensive overview of the RNA Transcriptomics market along with analysis of the changing dynamics of the market
Growth Assessment of various market segments throughout the forecast period
Regional and global analysis of the market players, including their market share and global position
Growth strategies adopted by key market players to combat the impact of the COVID-19 pandemic on the market
Impact of the technological developments and R&D advancements on the RNA Transcriptomics market
Information about profit-making strategies and developmental strategies of major companies and manufacturers
Insightful information for the new entrants willing to enter the market
Details and insights about business expansion strategies, product launches, and other collaborations
The report incorporates advanced analytical tools such as SWOT analysis, Porter's Five Forces Analysis, feasibility analysis, and investment return analysis
Check Our Prices@ https://www.emergenresearch.com/select-license/610
Global RNA Transcriptomics Market has been developing at a rapid rate and is contributing significantly to the global economy in terms of revenue, growth rate, sales, market share, and size. The Global RNA Transcriptomics Market report is a comprehensive research document that provides valuable insights to the readers to understand the fundamentals of the RNA Transcriptomics market.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018-2028
Chapter 3. Key Insights
Chapter 4. Global RNA Transcriptomics Market Segmentation & Impact Analysis
4.1. Global RNA Transcriptomics Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing demand for personalized medicine.
4.2.2.2. Rising applications of RNA sequencing.
4.2.3. Market restraints analysis
4.2.3.1. lack of skilled professionals.
4.2.3.2. Expensive research process
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
CONTINUE…!
You Can Download Free Sample PDF Copy of this Report At: https://www.emergenresearch.com/request-sample/610
Thank you for reading our report. To request a customization or for further inquiries, kindly get in touch with us. Our team will ensure the report is tailored meet to your needs.
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs